Slide background

Slide background
Slide background
Slide background

Loading Events
March
2019
5
New York Cancer Genomics Research Network Meeting

5:00 PM — 8:00 PM

Moderated by Harold Varmus, MD

See New York Genome Center’s lecture series, events and archives VIEW FULL CALENDAR

About

To advance collaborative efforts on cancer genomics, the New York Genome Center (NYGC) hosts meetings on the first Tuesday of every month to bring together leading cancer researchers, clinicians and postdocs from the NYGC’s Institutional Founding Members and other key academic institutions. The organizers include Drs. Harold Varmus (NYGC & Weill Cornell Medicine), Marcin Imielinski (NYGC &Weill Cornell Medicine), Ross Levine (Memorial Sloan Kettering Cancer Center) and Sohail Tavazoie (The Rockefeller University). 

WHEN:
Tuesday, March 5, 2019
5:00 PM – 7:00 PM: Speaker Presentations and Q&A
7:00 PM – 8:00 PM: Hors d’oeuvres & Networking

WHERE:
New York Genome Center
101 Avenue of the Americas, 1st Floor Auditorium

REGISTER

MODERATOR
Harold Varmus, MD 
Senior Associate Core Member
New York Genome Center

Lewis Thomas University Professor of Medicine
Weill Cornell Medicine

 

 

 

SPEAKERS

Peter Sims, PhD
Assistant Professor of Systems Biology (in Biochemistry and Molecular Biophysics and in Systems Biology)
Director, Columbia Single Cell Analysis Core
Director, Systems Biology Graduate Studies
Columbia University Irving Medical Center

 

“Deconvolving Cell Type-Specific Drug Response in Brain Tumors with Single-Cell Genomics”

 

Dr. Sims earned his PhD in chemistry from Harvard University with Sunney Xie where he developed tools for single molecule biophysics and DNA sequencing. In 2012, he became an Assistant Professor at Columbia University where he holds appointments in both the Dept. of Systems Biology and the Dept. of Biochemistry & Molecular Biophysics. He is also Director of Systems Biology Graduate Studies and Director of the Columbia Single Cell Analysis Core. His laboratory develops technology for single cell analysis and high-throughput genomic measurements with a particular emphasis on cancer and neurological disorders.

To learn more about Dr. Sims’ research, visit his lab page.

 

Britta Will, PhD
Assistant Professor, Department of Medicine (Oncology)
Assistant Professor, Department of Cell Biology
Albert Einstein College of Medicine

 

Stem Cell Aging and Malignant Transformation”

 

Dr. Will is an Assistant Professor in the Department of Medicine and the Department of Cell Biology at the Albert Einstein College of Medicine and her research focuses on: (1) Uncovering molecular mechanisms that prevent hematopoietic stem cell aging, (2) identification of age-related disease-predisposing molecular alterations in hematologic malignancies, and (3) therapeutic eradication of aberrant hematopoietic stem cells in degenerative and malignant diseases of the hematopoietic system. As the management of these adult stem cell-derived diseases is still inefficient, they constitute a considerable health problem due to the lack of knowledge of the molecular and cellular underpinnings driving adult stem cell aging. Dr. Will’s research program focuses on this imminent need. In addition, Dr. Will is the Director of the Cancer Stem Cell Pharmacodynamics Laboratory of the Albert Einstein Cancer Center, which assesses efficacy and mechanistic determinants of novel therapeutic compounds at the stem cell level by using pre-clinical model systems in collaboration with pharmaceutical industry partners.

To learn more about Dr. Will’s research, visit her lab page.

 

 

Mihaela Skobe, PhD
Associate Professor
Department of Oncological Sciences and Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai

 

“Lymphatics in Breast Cancer Progression”

 

Dr. Skobe is an Associate Professor in the Department of Oncological Sciences at the Icahn School of Medicine at Mount Sinai. Her laboratory investigates the mechanisms by which lymphatic vasculature supports and promotes malignant cancer behavior. Dr. Skobe’s pioneering work provided important insights into the role of lymphangiogenesis in cancer metastasis, and the function of lymphatic endothelial cells in immune response. Ultimate goal is to better understand the role of lymphatics in the tumor microenvironment and to exploit this knowledge to develop new diagnostic and therapeutic approaches.

To learn more about Dr. Skobe’s research, visit her lab page.

 

 

Discussion and Q&A
Moderated by Harold Varmus, MD
Discussion and Q&A will take place after each speaker presents.
These meetings are held on the first Tuesday of each month and are intended for principal investigators in the New York region and their trainees.
Any questions on this event, contact events@nygenome.org.

 

  • EVENING TALKS
    The New York Genome Center’s Evening Talks events feature distinguished experts from around the world sharing genomic insights and research. They are intended to showcase and explain high science to the non-scientific community. Speakers present the latest research findings and explain its implication for helping improve clinical care for a wide array of serious diseases. The lecture is followed by a lively question-and-answer session and a post-event reception of hors d’oeuvres and cocktails. These popular free public events are held in the Center’s state-of-the-art ground-floor auditorium starting at 6:30 pm. The Evening Talks Series is sponsored by The New York Community Trust – Pyewacket Fund.

  • Workshops